London, United Kingdom

Fabrizio Fina


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabrizio Fina: Innovator in Pharmaceutical Formulations

Introduction

Fabrizio Fina is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative approaches to solid dosage forms. His work is characterized by a blend of advanced technology and practical applications in medicine.

Latest Patents

Fina holds a patent for "Solid pharmaceutical dosage formulations and processes." This patent describes a process for producing a solid pharmaceutical dosage formulation using powder bed fusion selective laser 3-dimensional printing. The formulation comprises a mixture of a drug and an excipient, where at least one of these components absorbs electromagnetic radiation emitted by the laser. This innovative method enhances the efficiency and effectiveness of drug delivery systems.

Career Highlights

Fabrizio Fina is associated with UCL Business Plc, where he applies his expertise in pharmaceutical sciences. His work focuses on developing cutting-edge solutions that improve patient outcomes through better medication delivery systems. With a patent portfolio that includes 1 patent, he continues to push the boundaries of pharmaceutical innovation.

Collaborations

Fina collaborates with esteemed colleagues such as Abdul Waseh Basit and Alvaro Goyanes. These partnerships foster a dynamic environment for research and development, leading to advancements in the field of pharmaceuticals.

Conclusion

Fabrizio Fina is a pioneering inventor whose work in solid pharmaceutical dosage formulations exemplifies the intersection of technology and healthcare. His contributions are vital for the future of drug delivery systems, and his innovative spirit continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…